Takashi Kaneko

Takashi Kaneko

Auto-generated profile, based on publicly available information

Takashi Kaneko

Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2018 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
HMHaruo Miwa
Haruo Miwa
KNKazushi Numata
Kazushi Numata
KSKazuya Sugimori
Kazuya Sugimori
KSKatsuyuki Sanga
Katsuyuki Sanga
AHAkane Hirotani
Akane Hirotani
Shin MaedaShin Maeda
Shin Maeda

7 October 2013 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
PDF file
TKTakashi Kaneko
Takashi Kaneko
KSKazuya Sugimori
Kazuya Sugimori
YSYuro Shimizu
Yuro Shimizu
HMHaruo Miwa
Haruo Miwa
EKEri Kameta
Eri Kameta
SMShin Maeda
Shin Maeda

29 September 2021 in DEN Open
Verified
Journal Article
Open access
PDF file
HMHaruo Miwa
Haruo Miwa
KSKazuya Sugimori
Kazuya Sugimori
HTHiromi Tsuchiya
Hiromi Tsuchiya
MSMakoto Sugimori
Makoto Sugimori
MNMasaki Nishimura
Masaki Nishimura
Shin MaedaShin Maeda
Shin Maeda
Objectives: Recently, a novel clip device, SureClip® (Micro‐Tech Co. Ltd., Nanjing, China), has been developed, which improved rotation and reopening performance. We aimed to assess the efficacy of the SureClip® in prophylactic closure of the mucosal break after endoscopic papillectomy (EP) for ampullary neoplasm.Methods: We retrospectively reviewed the medical records of 40 patients who underwent EP for ampullary neoplasms between October 2009 and March 2020. Prophylactic closure after resection was performed using the conventional clip between 2014 and 2018, and with the SureClip® after 2019. The baseline characteristics, techniques, outcomes, and complications of EP were analyzed.Results: The median age of the patients (25 males and 15 females) was 70 years. The en block resection rate was 82.5% and the curative resection rate was 80.0%. Histologically, 11 (27.5%) patients had malignancy. Prophylactic closure was performed in 29 (72.5%) patients (17 conventional clips, 12 SureClip®). Complications occurred in 18 (45.0%) patients, including postprocedure bleeding in 9 (22.5%) patients. However, no postprocedure bleeding was observed in the patients who received prophylactic closure using the SureClip® (p = 0.038). All other factors were not significantly correlated with postprocedure bleeding. The duration of hospital stay after EP was significantly shorter in patients treated with the SureClip® compared to those treated with a conventional clip or without clips (p < 0.05).Conclusions: In the present study, prophylactic clipping of the mucosal break using the SureClip® was effective in preventing bleeding after EP.

24 April 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
HMHaruo Miwa
Haruo Miwa
KSKazuya Sugimori
Kazuya Sugimori
SYShoichiro Yonei
Shoichiro Yonei
HYHayato Yoshimura
Hayato Yoshimura
KEKazuki Endo
Kazuki Endo
Shin MaedaShin Maeda
Shin Maeda
The differential diagnosis of solid pancreatic lesions (SPLs) using B-mode endoscopic ultrasonography (EUS) is challenging. Detective flow imaging (DFI) offers the potential for detecting low-flow vessels in the pancreas, thus enhancing diagnostic accuracy. This retrospective study aimed to investigate DFI-EUS findings of SPLs and analyze their differential diagnostic accuracy for pancreatic cancer. We included 104 patients with pathologically confirmed SPLs who underwent EUS between April 2021 and June 2023. Expert endosonographers, blinded to the patients’ clinical data, evaluated images obtained through B-mode, eFLOW, and DFI-EUS. The frame rate and vessel detection sensitivity were compared between eFLOW and DFI, and the diagnostic criteria for pancreatic cancer were established. The visualization rate for vessels in SPLs was significantly higher with DFI-EUS (96%) compared to eFLOW (27%). Additionally, DFI showed a superior frame rate, sensitivity (99%), and accuracy (88%) for detecting pancreatic cancer, although with a modest specificity (43%). On DFI-EUS, characteristics such as hypovascularity, peritumoral vessel distribution, or spotty vessel form were suggestive of pancreatic cancer. DFI-EUS significantly improved the visualization of vascular structures within the SPLs, highlighting its efficacy as a diagnostic modality for pancreatic cancer.

16 January 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
KEKazuki Endo
Kazuki Endo
HMHaruo Miwa
Haruo Miwa
KSKazuya Sugimori
Kazuya Sugimori
KSKozue Shibasaki
Kozue Shibasaki
SYShoichiro Yonei
Shoichiro Yonei
Shin MaedaShin Maeda
Shin Maeda
Background/Objectives: Detective flow imaging (DFI) endoscopic ultrasonography (EUS) can identify the microvascular flow imaging of a mural nodule (MN) in an intraductal papillary mucinous neoplasm (IPMN) without the use of contrast agents. This retrospective study evaluated the diagnostic accuracy of DFI-EUS and its ability to evaluate the blood flow of MNs in IPMNs. Methods: Between April 2021 and September 2023, 68 patients with MNs in IPMNs observed on EUS images were retrospectively analyzed. Both DFI-EUS and contrast-enhanced EUS (CE-EUS) were performed during the same session. Three expert endosonographers blinded to the patients’ clinical data assessed the MN images obtained with CE-EUS and DFI-EUS. First, DFI-EUS images were evaluated using a predefined scoring system; thereafter, CE-EUS images were evaluated. The diagnostic capability of DFI-EUS to detect MN blood flow was assessed with CE-EUS as the gold standard. Secondary outcomes included inter-reader agreement, the correlation between MN size and detection rates, and the association between DFI blood flow signal patterns and malignancy of MNs in surgically resected cases. Results: CE-EUS showed a contrast effect in the MN in 24 cases. Among these, DFI-EUS detected blood flow signals in 20 cases; false-positive results were not observed. DFI-EUS demonstrated a sensitivity of 83%, specificity of 100%, and accuracy of 93% for detecting MN blood flow. Inter-reader agreement was substantial (kappa values, 0.6–0.8). The subgroup analysis revealed that all MNs ≥ 10 mm had detectable blood flow on DFI-EUS, whereas MNs < 10 mm had reduced detection rates (75%; 12/16 cases). No significant correlation between the DFI blood flow signal patterns and MN malignancy of resected cases was observed. Conclusions: DFI-EUS demonstrated high diagnostic accuracy for detecting MN blood flow. Because of its simplicity and cost-effectiveness, DFI-EUS could be an alternative to CE-EUS for patients with MNs inside IPMNs.

4 January 2023 in Endoscopy
Verified
Journal Article
Open access
PDF file
TITomohiro Ishii
Tomohiro Ishii
TKTakashi Kaneko
Takashi Kaneko
AMAyumi Murakami
Ayumi Murakami
MEMasato Enomoto
Masato Enomoto
KSKazuya Sugimori
Kazuya Sugimori
SMShin Maeda
Shin Maeda
Texture and color enhancement imaging (TXI) and red dichromatic imaging (RDI) modes are new image-enhancement options available on the EVIS X1 system (Olympus Corporation, Tokyo, Japan). TXI emphasizes slight differences in color tone and structural changes on the mucosal surface under normal light [1], whereas RDI may improve the visibility of deep blood vessels [2]. We previously reported the use of TXI- and RDI-mode cholangioscopy (CHF-B290, Olympus Corporation) in cholangiocarcinoma [3]. Here, we describe this technique in a patient with IgG4-related sclerosing cholangitis (IgG4-SC) and autoimmune pancreatitis (AIP). An 87-year-old woman presented with elevated liver enzymes and diffuse pancreatic enlargement ([Fig. 1], [Fig. 2]). Endoscopic retrograde cholangiopancreatography (ERCP) revealed segmental stenosis of the distal bile duct, preventing passage of the cholangioscope. A biliary stent was placed. Histopathology revealed no malignant findings; high IgG and IgG4 levels led to the diagnosis of AIP + IgG4-SC. Due to the patient’s age, stent replacement and stenosis reassessment were performed 2 months later without medication. The second ERCP showed slight improvement in stenosis, allowing passage of the cholangioscope. Cholangioscopy revealed partially dilated and slightly tortuous vessels without encasement or fusion [4] at the hilar bile duct. Dilated vessels were more clearly observed, and the fine surface structures of the thickened mucosa were more pronounced in TXI mode 1 than with white-light imaging. In RDI mode 3, the color of the bile disappeared and the dilated vessels were more strongly accentuated than with TXI. The mucosal surface was smooth, and no tumor vessels were observed at the stenosis ([Video 1]). The addition of TXI and RDI to cholangioscopy may therefore aid the diagnosis of IgG4-SC. A third ERCP 4 months later showed slight bile duct stenosis that did not require stenting; no adverse events or recurrence of symptoms were observed over the 10-month follow-up period. Video 1 Findings of the cholangioscopy using texture and color enhancement imaging mode 1 and red dichromatic imaging mode 3 in a patient with IgG4-related sclerosing cholangitis and autoimmune pancreatitis. Endoscopy_UCTN_Code_TTT_1AR_2AG Article published online: 30 August 2023 © 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany